Patent | Date |
---|
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20220296556 - MAGUIRE; Martin P. | 2022-09-22 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20220142963 - MAGUIRE; Martin P. ;   et al. | 2022-05-12 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20220040139 - MAGUIRE; Martin P. | 2022-02-10 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20210315855 - MAGUIRE; Martin P. ;   et al. | 2021-10-14 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20210205258 - MAGUIRE; Martin P. | 2021-07-08 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20210059972 - MAGUIRE; Martin P. ;   et al. | 2021-03-04 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20200368195 - MAGUIRE; Martin P. | 2020-11-26 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20200230097 - MAGUIRE; Martin P. ;   et al. | 2020-07-23 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20200121631 - Maguire; Martin P. | 2020-04-23 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20190380993 - MAGUIRE; Martin P. ;   et al. | 2019-12-19 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20190269643 - MAGUIRE; Martin P. | 2019-09-05 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20190142781 - MAGUIRE; Martin P. ;   et al. | 2019-05-16 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20190022048 - MAGUIRE; Martin P. | 2019-01-24 |
Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof Grant 10,117,848 - Maguire November 6, 2 | 2018-11-06 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20180280339 - MAGUIRE; Martin P. ;   et al. | 2018-10-04 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,522 - Maguire , et al. July 3, 2 | 2018-07-03 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,524 - Maguire , et al. July 3, 2 | 2018-07-03 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,523 - Maguire , et al. July 3, 2 | 2018-07-03 |
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20180110752 - MAGUIRE; Martin P. | 2018-04-26 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312241 - MAGUIRE; Martin P. ;   et al. | 2017-11-02 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312243 - MAGUIRE; Martin P. ;   et al. | 2017-11-02 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312242 - MAGUIRE; Martin P. ;   et al. | 2017-11-02 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,737,503 - Maguire , et al. August 22, 2 | 2017-08-22 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20160374982 - MAGUIRE; Martin P. ;   et al. | 2016-12-29 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,463,179 - Maguire , et al. October 11, 2 | 2016-10-11 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20160074354 - MAGUIRE; Martin P. ;   et al. | 2016-03-17 |
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,227,918 - Maguire , et al. January 5, 2 | 2016-01-05 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20140296335 - MAGUIRE; Martin P. ;   et al. | 2014-10-02 |
Short acting benzothiazepine calcium channel blockers and uses thereof Grant 8,501,727 - Maguire , et al. August 6, 2 | 2013-08-06 |
Short Acting Benzothiazepine Calcium Channel Blockers And Uses Thereof App 20110144087 - Maguire; Martin P. ;   et al. | 2011-06-16 |
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20100190852 - Maguire; Martin P. ;   et al. | 2010-07-29 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 7,550,597 - Myers , et al. June 23, 2 | 2009-06-23 |
Melanocortin-4 receptor binding compounds and methods of use thereof App 20080269217 - Vos; Tricia J. ;   et al. | 2008-10-30 |
Melanocortin-4 receptor binding compounds and methods of use thereof Grant 7,375,125 - Vos , et al. May 20, 2 | 2008-05-20 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases App 20050182054 - Myers, Michael R. ;   et al. | 2005-08-18 |
Antagonists of melanin concentrating hormone receptor Grant 6,921,821 - Blackburn , et al. July 26, 2 | 2005-07-26 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,852,712 - Myers , et al. February 8, 2 | 2005-02-08 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,846,815 - Myers , et al. January 25, 2 | 2005-01-25 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases Grant 6,821,962 - Myers , et al. November 23, 2 | 2004-11-23 |
Antagonists of melanin concentrating hormone receptor App 20040106645 - Blackburn, Christopher ;   et al. | 2004-06-03 |
Melanocortin-4 receptor binding compounds and methods of use thereof App 20040082779 - Vos, Tricia J. ;   et al. | 2004-04-29 |
Melanocortin-4 receptor binding compounds and methods of use thereof Grant 6,699,873 - Maguire , et al. March 2, 2 | 2004-03-02 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,696,434 - Myers , et al. February 24, 2 | 2004-02-24 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase App 20040014774 - Myers, Michael R. ;   et al. | 2004-01-22 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase Grant 6,645,969 - Myers , et al. November 11, 2 | 2003-11-11 |
Methods of treating insulin resistance syndrome and diabetes App 20030176390 - Herling, Andreas ;   et al. | 2003-09-18 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases App 20030144284 - Myers, Michael R. ;   et al. | 2003-07-31 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases App 20030139400 - Myers, Michael R. ;   et al. | 2003-07-24 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases App 20030139399 - Myers, Michael R. ;   et al. | 2003-07-24 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases App 20030130285 - Myers, Michael R. ;   et al. | 2003-07-10 |
Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties Grant 6,559,313 - Myers , et al. May 6, 2 | 2003-05-06 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,528,526 - Myers , et al. March 4, 2 | 2003-03-04 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,524,347 - Myers , et al. February 25, 2 | 2003-02-25 |
Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties App 20020099030 - Myers, Michael R. ;   et al. | 2002-07-25 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase Grant RE37,650 - Myers , et al. April 9, 2 | 2002-04-09 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Grant 6,180,632 - Myers , et al. January 30, 2 | 2001-01-30 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases Grant 6,159,978 - Myers , et al. December 12, 2 | 2000-12-12 |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 6,057,320 - Spada , et al. May 2, 2 | 2000-05-02 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant RE36,256 - Spada , et al. July 20, 1 | 1999-07-20 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 5,795,889 - Spada , et al. August 18, 1 | 1998-08-18 |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties Grant 5,721,237 - Myers , et al. February 24, 1 | 1998-02-24 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase Grant 5,714,493 - Myers , et al. February 3, 1 | 1998-02-03 |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 5,710,158 - Myers , et al. January 20, 1 | 1998-01-20 |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 5,656,643 - Spada , et al. A | 1997-08-12 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 5,646,153 - Spada , et al. July 8, 1 | 1997-07-08 |
Polyarylcarbamoylaza- and -carbamoylalkanedioic acids Grant 5,556,990 - Pauls , et al. September 17, 1 | 1996-09-17 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase Grant 5,480,883 - Spada , et al. January 2, 1 | 1996-01-02 |